Pagerols, Mireia
Richarte, Vanesa
Sánchez-Mora, Cristina
Rovira, Paula
Soler Artigas, María
Garcia-Martínez, Iris
Calvo-Sánchez, Eva
Corrales, Montse
da Silva, Bruna Santos
Mota, Nina Roth
Victor, Marcelo Moraes
Rohde, Luis Augusto
Grevet, Eugenio Horacio
Bau, Claiton Henrique Dotto
Cormand, Bru
Casas, Miguel
Ramos-Quiroga, Josep Antoni
Ribasés, Marta
Article History
Received: 31 May 2017
Accepted: 15 January 2018
First Online: 30 January 2018
Competing Interests
: E.H.G. has served on the speakers’ bureau and has received travel grants from Shire and Novartis. He has also been on the advisory board and acted as a consultant for Shire. L.A.R. has served on the speakers’ bureau, acted as a consultant and received grant or research support from Eli Lilly and Co., Janssen-Cilag, Medice, Novartis, and Shire. The ADHD and Juvenile Bipolar Disorder Outpatient Programs chaired by L.A.R. have received unrestricted educational and research support from the following pharmaceutical companies: Eli Lilly and Co., Janssen-Cilag, Novartis, and Shire. L.A.R. has received travel grants from Shire to take part in the 2014 APA, 2015 WFADHD and 2016 AACAP congresses. He has received royalties from Artmed Editora and Oxford University Press. Prof. M.C. has received travel grants and research support from Eli Lilly and Co., Janssen-Cilag, Shire, and Laboratorios Rubió. He has been on the advisory board and served as a consultant for Eli Lilly and Co., Janssen-Cilag, Shire, and Laboratorios Rubió. J.A.R.Q. has served on the speakers’ bureau and acted as a consultant for Eli Lilly and Co., Janssen-Cilag, Novartis, Lundbeck, Shire, Ferrer, and Laboratorios Rubió. He has received travel awards from Eli Lilly and Co., Janssen-Cilag, and Shire for participating in psychiatric meetings. The ADHD Program chaired by J.A.R.Q. has received unrestricted educational and research support from Eli Lilly and Co., Janssen-Cilag, Shire, Rovi, and Laboratorios Rubió in the past two years. The remaining authors declare no conflict of interest.